| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $592.2M | +8.3% | +34.7% |
| Gross Profit | $723.5M | — | — |
| R&D Expense | $173.4M | +18.4% | +78.9% |
| SG&A Expense | $308.5M | -0.6% | +44.1% |
| Operating Income | -$97.6M | +11.6% | -148.0% |
| Interest Expense | $1.0M | +1.6% | -66.7% |
| Pre-tax Income | -$87.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $1.0M | -93.7% | -96.6% |
| Accounts Receivable | $286.4M | -7.4% | -6.7% |
| Inventory | $64.6M | +19.1% | +32.7% |
| Current Assets | $1.45B | +1.1% | +9.4% |
| Total Assets | $1.82B | +3.7% | +14.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $141.4M | — | — |
| Capital Expenditures | $70.1M | — | — |
| Investing Cash Flow | -$60.6M | — | — |
| Financing Cash Flow | $15.1M | — | — |
| Free Cash Flow | $71.3M | — | — |
| +13.2% |
| -183.0% |
| Income Tax | $207K | -24.7% | -71.6% |
| Net Income | -$87.5M | +13.3% | -177.1% |
| EPS (Basic) | -$0.64 | +13.5% | -146.2% |
| EPS (Diluted) | -$0.64 | +13.5% | -146.2% |
| $442.0M |
| +14.9% |
| +46.6% |
| Total Liabilities | $569.3M | +11.4% | -20.1% |
| Stockholders' Equity | $1.25B | +0.5% | +42.5% |